Artificial Intelligence
Members
-
Alexandre LeBouthillier, Co-Chair
Imagia -
Rania El-Masri, Co-Chair
GlaxoSmithKline -
Nadine Beauger
Institut de recherche en immunologie et en cancérologie, Commercialisation de la recherche -
Frank Béraud
Montréal InVivo -
Vanessa Claveau
Ministry of Economy and Innovation -
Jacques deGuise
École des technologies supérieure et Centre Hospitalier de l'Université de Montréal -
Francois Drolet
Roche -
Christelle Fasano
Montréal International -
Pierre Alexandre Fournier
Hexoskin -
Sarah Jenna
MyIntelligentMachineS -
Meryeme Lahmami
MEDTEQ -
Paul L'Archevêque
Bureau de l'innovation, Ministry of Health and Social Services -
Benoit Larose
MEDEC -
Martin Leblanc
Caprion -
Stéphane Létourneau
MILA -
Caroline Ménard
Innovation, Sciences et Développement économique Canada -
Samir Mounir
Desjardins - Caisse du réseau de la santé -
Nolwenn Noisel
Cartagene -
Doina Precup
Healthy Brains for Healthy Lives, McGill University -
Jean-Pierre Robert
CTS Santé -
Louis Roy
IBM Corporation -
Shane Russell
Medtronic Canada -
Michelle Savoie
Québec network for Personalized Health Care -
Luc Sirois
PROMPT -
Luc Vilandré
TELUS Santé
Coordination
-
Marie-Lise Dion
Montréal InVivo
Mandate
Promote the economic development of a life sciences and health technologies (LSHT) sector in life sciences and health technologies powered by AI, from the diagnostic to therapy and so for health prevention.
- Development and growth of AI - LSHT organizations.
- Development and growth of LSHT organizations through AI application.
Priorities and achievements
Created in 2018, the committee works for the mobilization of stakeholders in various LSHT segments (Biopharmaceuticals, Medical Technology, Health ITC, CRO, …) towards the economic development of the AI in LSHT.
Priorities 2019-2020
#1. Elaborate a strategy for a differentiated developement of the sector.
#2. Facilitate the collaboration between the actors (development and adoption of IA - LSHT)
#3. Ensure a comprehensive and a compliant funding chain applied to AI in LSHT.